A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays (vol 7, 100139, 2023)

被引：0
|
作者：
Colpani, Paola [1 ]
Baronciani, Luciano [1 ]
Stufano, Francesca [1 ]
Cozzi, Giovanna [1 ]
Boscarino, Marco [1 ]
Pagliari, Maria Teresa [1 ]
Biguzzi, Eugenia [1 ]
Peyvandi, Flora [1 ,2 ]
机构：
[1] Fdn IRCCS Cagranda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2023年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Visualizing the von willebrand factor/glycoprotein ib-IX axis in platelet-type von willebrand disease
    Guerrero, J. A.
    Russell, S.
    Gartner, T. K.
    Storrie, B.
    Ware, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 344 - 344
  • [32] VON WILLEBRAND DISEASE TYPE 2A DUE TO A RARE VON WILLEBRAND FACTOR MISSENSE MUTATION
    Van Helmond, Jennifer
    Chopra, Aarushi
    Hernandez, Jessa
    Mysore, Sukrita
    Ahmed, Rafat
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S73 - S73
  • [33] The Y/C1584 mutation of von Willebrand factor in type 2M von willebrand disease: frequency and clearance of von Willebrand factor
    Millar, CM
    Riddel, AF
    Griffioe, A
    Jenkin, PV
    Brown, SA
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 462 - 463
  • [34] EVALUATION OF THE DIFFERENT PLATELET-DEPENDENT VON WILLEBRAND FACTOR ACTIVITY ASSAYS CAPACITY TO ASSESS THE IN VIVO INHIBITORY EFFECT OF CAPLACIZUMAB ON THE VWF-PLATELET INTERACTION.
    Colpani, P.
    Baronciani, L.
    Novembrino, C.
    Mancini, M.
    Cozzi, G.
    De Leo, P.
    Galbiati, E.
    Boscarino, M.
    Artoni, A.
    Peyvandi, F.
    HAEMATOLOGICA, 2021, 106 (09) : 9 - 10
  • [35] von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2
    Veyradier, A.
    Trossaert, M.
    Lefrancois, A.
    Fressinaud, E.
    Meyer, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 868 - 870
  • [36] Increased O-linked glycosylation of von Willebrand factor in patients with von Willebrand disease type 1
    Van Schooten, CJM
    Van den Berg, HM
    De Groot, PG
    Lenting, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 18 - 19
  • [37] Mutational analysis of the von Willebrand factor gene in patients affected by type 3 von Willebrand disease.
    Baronciani, L
    Cozzi, G
    Canciani, MT
    Forza, I
    Peyvandi, F
    Srivastava, A
    Federici, AB
    Mannucci, PM
    BLOOD, 2000, 96 (11) : 566A - +
  • [38] An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type I von Willebrand disease
    Cumming, Anthony
    Grundy, Pamela
    Keeney, Stephen
    Lester, William
    Enayat, Said
    Guilliatt, Andrea
    Bowen, Derrick
    Pasi, John
    Keeling, David
    Hill, Frank
    Bolton-Maggs, Paula H. B.
    Hay, Charles
    Collins, Peter
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (05) : 630 - 641
  • [39] Von Willebrand factor levels do not increase with age in patients with type 1 von Willebrand disease.
    Tarng, HI
    Taylor, L
    Konkle, BA
    BLOOD, 2004, 104 (11) : 93B - 93B
  • [40] Comparative analysis of type 2b von Willebrand disease mutations: Implications for the mechanism of von Willebrand factor binding to platelets
    Cooney, KA
    Ginsburg, D
    BLOOD, 1996, 87 (06) : 2322 - 2328
12345